Panacea Index Logo

Command Palette

Search for a command to run...

Improved glucose metabolism after gastric bypass: evolution of the paradigm.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
January 1, 2016
Dimitri J Pournaras et al. (6 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to quantify the contributions of calorie restriction, nutrient rerouting, and adipose tissue reduction to improved glucose metabolism after Roux-en-Y gastric bypass (RYGB) in type 2 diabetes patients.

Results Summary

The study found that RYGB improved whole-body insulin sensitivity and postprandial glucose response early after surgery, with further improvements at one year. Calorie restriction and nutrient rerouting contributed through distinct mechanisms, while weight loss enhanced insulin sensitivity via increased glucose oxidation and nonoxidative glucose disposal.

Population

Fifteen diabetic patients (age 47±9 years, BMI 41.3±4.2 kg/m²).

Effective Dosage

Not specified

Duration

2 weeks of very low-calorie diet (VLCD) pre-surgery, 2 weeks post-surgery, and 1-year follow-up.

Interactions

None mentioned

Extracted Claims (12)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Roux-en-Y gastric bypass (RYGB)
increase
glucose metabolism
patients with type 2 diabetes
-
improved
#1
very low calorie diet (VLCD)
increase
M (insulin sensitivity)
diabetic patients
2.9±1.3 to 4.2±1.1 mg/kg/min
improved
#2
very low calorie diet (VLCD)
no change
M (insulin sensitivity)
diabetic patients
-
no further change
#3
Roux-en-Y gastric bypass (RYGB)
no change
M (insulin sensitivity)
diabetic patients
4.7±1.7 versus 4.2±1.1
similar
#4
Roux-en-Y gastric bypass (RYGB)
increase
M (insulin sensitivity)
diabetic patients
-
improved further
#5
very low calorie diet (VLCD) and Roux-en-Y gastric bypass (RYGB)
increase
insulin-stimulated glucose uptake
diabetic patients
-
entirely accounted for
#6
weight loss
increase
nonoxidative glucose disposal (NOGD) and glucose oxidation
diabetic patients
-
associated with an increase
#7
very low calorie diet (VLCD)
increase
postprandial glucose
diabetic patients
-
improved
#8
Roux-en-Y gastric bypass (RYGB)
increase
postprandial glucose
diabetic patients
-
improved even more
#9
Roux-en-Y gastric bypass (RYGB)
no change
postprandial glucose
diabetic patients
-
no further change
#10
Roux-en-Y gastric bypass (RYGB)
increase
whole-body insulin sensitivity and postprandial glucose response
-
-
improved
#11
weight loss
increase
whole-body insulin sensitivity, including glucose oxidation and NOGD
-
-
contributes by increasing
#12
Abstract

BACKGROUND: Glucose metabolism is improved in patients with type 2 diabetes after Roux-en-Y gastric bypass (RYGB). OBJECTIVES: To quantify the relative contribution of calorie restriction, rerouting of nutrients, and adipose tissue reduction. SETTING: University Hospital. METHODS: Fifteen diabetic patients, (47±9 yr, body mass index 41.3±4.2 kg/m RESULTS: In the VLCD group, after 2 weeks of calorie restriction, M improved (2.9±1.3 to 4.2±1.1 mg/kg/min, P = .005) with no further change at 2 weeks postoperatively. In the normal diet group 2 weeks postoperatively, M was similar to the VLCD group (4.7±1.7 versus 4.2±1.1, P = .61). One year postoperatively, M improved further in both groups. The improvement in insulin-stimulated glucose uptake after VLCD and RYGB was entirely accounted for by nonoxidative glucose disposal (NOGD), whereas weight loss at 1 year postoperatively was associated with an increase in NOGD and glucose oxidation. Postprandial glucose improved after VLCD (P<.05) and even more 2 weeks after RYGB (P<.05) with no further change after 1 year. CONCLUSION: Improved whole-body insulin sensitivity and postprandial glucose response occur early after RYGB. Low calorie intake and rerouting of nutrients contribute through distinct mechanisms. Weight loss contributes by increasing whole-body insulin sensitivity, including glucose oxidation and NOGD. These data suggest that the combination of different mechanisms is what makes RYGB an effective intervention for type 2 diabetes.

Medical Subject Headings (MeSH)
AdultAnalysis of VarianceBlood GlucoseCaloric RestrictionDiabetes Mellitus, Type 2FemaleGastric BypassGlucoseHumansHypoglycemic AgentsInfusions, IntravenousInsulinInsulin ResistanceMaleMiddle AgedObesity, MorbidPostprandial PeriodPreoperative Care
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations35
Citations/Year3.9
Relative Citation Ratio1.41
NIH Percentile63%
Research Impact Scores
APT Score0.95
Weight Score1.86
Normalized Score0.69
Related Supplements